首页|中医药调控程序性细胞死亡干预肝纤维化的研究进展

中医药调控程序性细胞死亡干预肝纤维化的研究进展

扫码查看
肝纤维化(HF)是一种由于慢性肝损伤导致的肝组织结构异常修复的病理过程,其发病机制尚未完全阐明.相关研究表明,程序性细胞死亡可能与HF的发生有关,而中医药在调控程序性细胞死亡干预HF方面有着显著疗效.本文概述了程序性细胞死亡影响HF的主要机制,并从中医角度出发探讨中医药调控程序性细胞死亡改善HF的可能机制,为中医药防治肝纤维化提供新思路.
Research advances in traditional Chinese medicine regulation of programmed cell death in intervening against hepatic fibrosis
Hepatic fibrosis(HF)is a pathological process of abnormal repair of liver tissue structure caused by chronic liver injury,and its pathogenesis has not been fully clarified.Related studies have shown that programmed cell death may be associated with the onset of HF,and traditional Chinese medicine(TCM)has a significant effect in regulating programmed cell death to intervene against HF.This article reviews the main mechanism of the influence of programmed cell death on HF and discusses the possible mechanism of TCM regulation of programmed cell death in improving HF,which provides new ideas for TCM prevention and treatment of HF.

Hepatic FibrosisTraditional Chinese DrugsProgrammed Cell Death

黄良江、毛德文、张荣臻、黄国初、王涵、秦伟彬、姚春

展开 >

广西中医药大学研究生院,南宁 530200

广西中医药大学第一附属医院肝病科,南宁 530023

肝纤维化 中药 程序性细胞死亡

广西壮族自治区重点研发计划广西壮族自治区研究生教育创新计划广西壮族自治区学位与研究生教育改革项目

桂科AB22035076YCSW2022343JGY2022182

2024

临床肝胆病杂志
吉林大学

临床肝胆病杂志

CSTPCD北大核心
影响因子:1.428
ISSN:1001-5256
年,卷(期):2024.40(1)
  • 8